The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report

BMC Nephrology

Roland Seidel²  Danilo Fliser³  Philip Lepper¹  Aaron Poppleton³  Sarah Seiler³  Matthias Klingele³ 

[1] Department of Pneumology, Allergology, Artificial Ventilation and Environmental Medicine, Saarland University Medical Centre, Homburg-Saar, Germany;Department of Diagnostic and Interventional Radiology, Saarland University Medical Centre, Homburg-Saar, Germany;Department of Internal Medicine, Nephrology and Hypertension, Saarland University Medical Centre, Homburg-Saar, Germany

关键词: Renal replacement therapy;    Immobilisation;    Citrate anticoagulation;    Bone loss;   

Others  :  1082597
DOI  :  10.1186/1471-2369-15-163

 received in 2014-06-26, accepted in 2014-09-25,  发布年份 2014

【 摘 要 】

Background

Demineralisation and bone density loss during immobilisation are known phenomena. However information concerning the extent of calcium loss during immobilisation remains inconsistent within literature. This may explain why treatment of bone loss and prevention of further demineralisation is often initiated only when spontaneous bone fracture occurred.

Continuous renal replacement therapy is commonly utilised in critically ill patients with acute kidney injury requiring RRT. Regional anticoagulation with citrate for CRRT is well-established within the intensive care setting. Due to calcium free dialysate, calcium is eliminated directly as well as indirectly via citrate binding necessitating calcium substitution. In anuric patients declining calcium requirements over time reflect bone calcium liberation secondary to immobilisation. The difference between the expected and actual need for calcium infusion corresponds to calcium release from bone which is particularly impressive in patients exposed to long-term immobilisation and CRRT. We report a dialysis period in excess of 250 days with continuous renal replacement therapy and anticoagulation with citrate.

Case presentation

We present a 30-year old male with prolonged multisystem organ failure after bilateral lung transplantation, in whom during a period of 254 days the cumulative difference between expected and actual need for calcium infusion was 14.25 mol, representing an estimated calcium loss of about 571 g. Comparison of computed tomographic imaging of the lower thoracic vertebrae over this period depicts a radiographically discernible decrease in bone density from 238 to 52 Hounsfield Units. The first spontaneous fracture occurred after 6 months of immobilisation. Despite subsequent treatment with bisphosphonates and androgen therapy resulting in an increase in bone density to 90 HU a further fracture occurred.

Conclusion

In immobilised patients receiving CRRT and anticoagulation with citrate, decreasing need for calcium substitution reflects the degree of bone demineralisation corresponding with radiographic assessment of declining bone mineral density. Such a declining need for calcium substitution could be useful in clinical practice highlighting relevant bone loss which results in spontaneous fractures in immobilised critically ill patients.

【 授权许可】

   
2014 Klingele et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE: Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982, 306(19):1136-1140.
• [2]Wang PL, Meyer MM, Orloff SL, Anderson S: Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Am J Kidney Dis 2004, 44(6):1110-1114.
• [3]Vico L, Collet P, Guignandon A, Lafage-Proust MH, Thomas T, Rehaillia M, Alexandre C: Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet 2000, 355(9215):1607-1611.
• [4]Hulley SB, Vogel JM, Donaldson CL, Bayers JH, Friedman RJ, Rosen SN: The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest. J Clin Invest 1971, 50(12):2506-2518.
• [5]Parfitt AM: Bone effects of space flight: analysis by quantum concept of bone remodelling. Acta Astronaut 1981, 8(9–10):1083-1090.
• [6]Zerwekh JE, Ruml LA, Gottschalk F, Pak CY: The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 1998, 13(10):1594-1601.
• [7]Bauman WA, Spungen AM, Wang J, Pierson RN Jr, Schwartz E: Continuous loss of bone during chronic immobilization: a monozygotic twin study. Osteoporos Int 1999, 10(2):123-127.
• [8]Sievanen H: Immobilization and bone structure in humans. Arch Biochem Biophys 2010, 503(1):146-152.
• [9]Rittweger J, Simunic B, Bilancio G, De Santo NG, Cirillo M, Biolo G, Pisot R, Eiken O, Mekjavic IB, Narici M: Bone loss in the lower leg during 35 days of bed rest is predominantly from the cortical compartment. Bone 2009, 44(4):612-618.
• [10]Need AG, Morris HA, Horowitz M, Nordin BE: Immobilization hypercalcaemia with severe bone mineral loss and hypogonadism. Postgrad Med J 1984, 60(704):415-419.
• [11]Bergmann P, Heilporn A, Schoutens A, Paternot J, Tricot A: Longitudinal study of calcium and bone metabolism in paraplegic patients. Paraplegia 1977, 15(2):147-159.
• [12]Naftchi NE, Viau AT, Sell GH, Lowman EW: Mineral metabolism in spinal cord injury. Arch Phys Med Rehabil 1980, 61(3):139-142.
• [13]Weissman C, Askanazi J, Hyman AI, Weber C: Hypercalcemia and hypercalciuria in a critically ill patient. Crit Care Med 1983, 11(7):576-578.
• [14]Peacock M: Calcium metabolism in health and disease. Clin J Am Soc Nephrol 2010, 5(Suppl 1):S23-S30.
• [15]Sbaihi M, Rousseau K, Baloche S, Meunier F, Fouchereau-Peron M, Dufour S: Cortisol mobilizes mineral stores from vertebral skeleton in the European eel: an ancestral origin for glucocorticoid-induced osteoporosis? J Endocrinol 2009, 201(2):241-252.
• [16]Gruenewald DA, Matsumoto AM: Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 2003, 51(1):101-115. discussion 115
• [17]Lopez-Herce J, Santiago MJ, Solana MJ, Urbano J, del Castillo J, Carrillo A, Bellon JM: Clinical course of children requiring prolonged continuous renal replacement therapy. Pediatr Nephrol 2010, 25(3):523-528.
• [18]Rajgopal R, Bear M, Butcher MK, Shaughnessy SG: The effects of heparin and low molecular weight heparins on bone. Thromb Res 2008, 122(3):293-298.